ADVANCED OR METASTATIC SQUAMOUS NON-SMALL CELL LUNG CANCER
Clinical trials for ADVANCED OR METASTATIC SQUAMOUS NON-SMALL CELL LUNG CANCER explained in plain language.
Never miss a new study
Get alerted when new ADVANCED OR METASTATIC SQUAMOUS NON-SMALL CELL LUNG CANCER trials appear
Sign up with your email to follow new studies for ADVANCED OR METASTATIC SQUAMOUS NON-SMALL CELL LUNG CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for advanced lung cancer: experimental drug combo enters global trial
Disease control Recruiting nowThis study tests two experimental drugs, HLX43 and HLX07, alone or together, against a standard chemotherapy (docetaxel) in people with advanced squamous non-small cell lung cancer whose first treatment stopped working. About 706 adults worldwide will take part. The goal is to se…
Matched conditions: ADVANCED OR METASTATIC SQUAMOUS NON-SMALL CELL LUNG CANCER
Phase: PHASE2, PHASE3 • Sponsor: Shanghai Henlius Biotech • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New drug cocktail targets Hard-to-Treat cancers
Disease control Recruiting nowThis study tests a new antibody called HMBD-001 combined with two existing cancer drugs (cetuximab and docetaxel) in people with advanced squamous cell cancers of the lung, head and neck, esophagus, cervix, or skin. The goal is to see if the combination is safe and can shrink tum…
Matched conditions: ADVANCED OR METASTATIC SQUAMOUS NON-SMALL CELL LUNG CANCER
Phase: PHASE1, PHASE2 • Sponsor: Hummingbird Bioscience • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC